Skip Navigation
Skip to contents

Ann Coloproctol : Annals of Coloproctology

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
6 "Carcinomatosis"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Display
Original Article
Malignant disease
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy With Mitomycin C Used for Colorectal Peritoneal Carcinomatosis
Seung Jae Roh, Sung Chan Park, Jaehee Choi, Joon Sang Lee, Dong Woon Lee, Chang Won Hong, Kyung Su Han, Hyoung Chul Park, Dae Kyung Sohn, Jae Hwan Oh
Ann Coloproctol. 2020;36(1):22-29.   Published online February 29, 2020
DOI: https://doi.org/10.3393/ac.2019.04.30
  • 8,892 View
  • 182 Download
  • 24 Web of Science
  • 24 Citations
AbstractAbstract PDF
Purpose
This study aimed to assess the evaluation of clinical outcomes and consequences of complications after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for the peritoneal carcinomatosis (PC) from colorectal cancer.
Methods
A total 26 patients underwent CRS and HIPEC for PC from colorectal cancer between March 2009 and April 2018. All the patients underwent CRS with the purpose of complete or near-complete cytoreduction. Intraoperative HIPEC was performed simultaneously after the CRS. Mitomycin C was used as chemotherapeutic agent for HIPEC.
Results
Median disease-free survival was 27.8 months (range, 13.4–42.2 months). Median overall survival was 56.0 months (range, 28.6–83.5 months). The mean peritoneal cancer index (PCI) was 8.73 ± 5.54. The distributions thereof were as follows: PCI <10, 69.23%; PCI 10–19, 23.08%; and PCI ≥20, 7.69%. The completeness of cytoreduction was 96.2% of patients showed CC-0, with 3.8% achieved CC-1. The mean operation time was 8.5 hours, and the mean postoperative hospital stay was 21.6 days. The overall rate of early postoperative complications was 88.5%; the rate of late complications was 34.6%. In the early period, most complications were grades I–II complications (65.4%), compared to grades III–V (23.1%). All late complications, occurring in 7.7% of patients, were grades III–V. There was no treatment-related mortality.
Conclusion
Although the complication rate was approximately 88%, but the rate of severe complication rate was low. In selective patients with peritoneal recurrence, more aggressive strategies for management, such as CRS with HIPEC, were able to be considered under the acceptable general condition and life-expectancy.

Citations

Citations to this article as recorded by  
  • Mitomycin C-Based Hyperthermic Intraperitoneal Chemotherapy Improves Survival in Colorectal Cancer With Peritoneal Metastasis
    Chayanit Sirisai, Hathaiwan Moungthard, Kitinut Timudom, Saipan Khunpakdee
    Cureus.2026;[Epub]     CrossRef
  • Evolving therapeutics in colorectal cancer peritoneal metastases
    Justin M. Bader, Nicole Aguirre, Kurt S. Schultz, Kwasi Ansere Ofori, Elizabeth Godfrey, Princy Gupta, Robert Tseng, Michael Cecchini, Raghav Sundar, Kiran Turaga
    Cancer and Metastasis Reviews.2026;[Epub]     CrossRef
  • Harnessing Hyperthermia: Molecular, Cellular, and Immunological Insights for Enhanced Anticancer Therapies
    Szilvia Lukácsi, Gyöngyi Munkácsy, Balázs Győrffy
    Integrative Cancer Therapies.2024;[Epub]     CrossRef
  • Diagnostic and Prognostic Potential of Long Non-Coding RNAs GAS5, MALAT1, CCAT2, HOTAIR and H19 in Colorectal Cancer Cases with Peritoneal Metastases
    Alpaslan Tanoglu, Esra Guzel Tanoglu, Erdal Polat, Muhammed Fevzi Esen, Nagehan Ozdemir Barisik
    Brazilian Archives of Biology and Technology.2024;[Epub]     CrossRef
  • Albumin Leakage Level during Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Is Associated with Major Complications
    Hyun-Chang Kim, Dong Woo Han, Eun Jung Park, Yeon Hwa Hong, Young Song
    Cancers.2024; 16(16): 2874.     CrossRef
  • Challenges following CRS and HIPEC surgery in cancer patients with peritoneal metastasis: a comprehensive review of clinical outcomes
    Mehdi Karimi, Niyousha Shirsalimi, Eshagh Sedighi
    Frontiers in Surgery.2024;[Epub]     CrossRef
  • Analgesic effects of combined transversus abdominis plane block and intramuscular electrical stimulation in patients undergoing cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy: a randomized controlled trial
    Hyun-Chang Kim, Jinyoung Park, Jinyoung Oh, Minjae Kim, Eun Jung Park, Seung Hyuk Baik, Young Song
    International Journal of Surgery.2023; 109(5): 1199.     CrossRef
  • The Design of an Automatic Temperature Compensation System through Smart Heat Comparison/Judgment and Control for Stable Thermal Treatment in Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Surgery
    Kicheol Yoon, Sangyun Lee, Tae-Hyeon Lee, Kwang Gi Kim
    Sensors.2023; 23(15): 6722.     CrossRef
  • Epidemiology of psychiatric disorders following cytoreductive surgeries plus hyperthermic intraperitoneal chemotherapy: a prospective cohort analysis
    Guillaume Economos, Vahan Kepenekian, Cécile Barbaret, Laurent Villeneuve, Julie Haesebaert, Olivier Glehen
    Scientific Reports.2023;[Epub]     CrossRef
  • Impact of Mitomycin-C-Induced Neutropenia after Hyperthermic Intraperitoneal Chemotherapy with Cytoreductive Surgery in Colorectal Cancer Patients with Peritoneal Carcinomatosis
    Suk Jun Lee, Youngbae Jeon, Hae Won Lee, Jeonghyun Kang, Seung Hyuk Baik, Eun Jung Park
    Annals of Surgical Oncology.2022; 29(3): 2077.     CrossRef
  • What is the ideal management of Krukenberg syndrome?
    Carolina Arró Ortiz, Darío Ramallo, Nicolás Guerrini
    Journal of Surgical Case Reports.2022;[Epub]     CrossRef
  • ASO Author Reflections: Is it Correct to Use 5% Dextrose Solution as a Carrier Fluid for Oxaliplatin-based HIPEC?
    Eun Jung Park, Sung-Joo Hwang, Seung Hyuk Baik
    Annals of Surgical Oncology.2022; 29(13): 8593.     CrossRef
  • Pharmacologic Effects of Oxaliplatin Instability in Chloride-Containing Carrier Fluids on the Hyperthermic Intraperitoneal Chemotherapy to Treat Colorectal Cancer In Vitro and In Vivo
    Eun Jung Park, Junhyun Ahn, Sharif Md Abuzar, Kyung Su Park, Sung-Joo Hwang, Seung Hyuk Baik
    Annals of Surgical Oncology.2022; 29(13): 8583.     CrossRef
  • Benign multicystic mesothelioma of appendiceal origin treated by hyperthermic intraperitoneal chemotherapy: A case report
    Suk Jun Lee, Ji Hae Nahm, Jeonghyun Kang, Seung Hyuk Baik, Eun Jung Park
    International Journal of Surgery Case Reports.2022; 99: 107665.     CrossRef
  • Molecular analyses of peritoneal metastasis from colorectal cancer
    Chang Hyun Kim
    Journal of the Korean Medical Association.2022; 65(9): 586.     CrossRef
  • Surgical treatment for metastatic colorectal cancer
    Eun Jung Park, Seung Hyuk Baik
    Journal of the Korean Medical Association.2022; 65(9): 568.     CrossRef
  • Molecular Analyses in Peritoneal Metastasis from Colorectal Cancer: A Review-An English Version
    Chang Hyun Kim
    Journal of the Anus, Rectum and Colon.2022; 6(4): 197.     CrossRef
  • Recent Advance in the Surgical Treatment of Metastatic Colorectal Cancer-An English Version
    Eun Jung Park, Seung Hyuk Baik
    Journal of the Anus, Rectum and Colon.2022; 6(4): 213.     CrossRef
  • Update on Diagnosis and Treatment of Colorectal Cancer
    Chan Wook Kim
    The Ewha Medical Journal.2022;[Epub]     CrossRef
  • Hyperthermic Intraperitoneal Chemotherapy Following Cytoreductive Surgery for Colorectal Peritoneal Carcinomatosis Patients: A Review
    Sarah S Alhumaidan, Abeer M Alharbi, Ayesha Farhana Syeda, Fatimah A Alghaidani, Manal M Almutairi, Nourah A Alharbi, Reham K Alenezi
    Cureus.2022;[Epub]     CrossRef
  • Hyperthermia generated by magnetic nanoparticles for effective treatment of disseminated peritoneal cancer in an orthotopic nude-mouse model
    Yuki Matsumi, Tetsuya Kagawa, Shuya Yano, Hiroshi Tazawa, Kunitoshi Shigeyasu, Sho Takeda, Toshiaki Ohara, Hiromichi Aono, Robert M. Hoffman, Toshiyoshi Fujiwara, Hiroyuki Kishimoto
    Cell Cycle.2021; 20(12): 1122.     CrossRef
  • Treatment for Peritoneal Metastasis of Patients With Colorectal Cancer
    Young Jin Kim, Chang Hyun Kim
    Annals of Coloproctology.2021; 37(6): 425.     CrossRef
  • Hyperthermic Intrathoracic Chemoperfusion for Malignant Pleural Mesothelioma: Systematic Review and Meta-Analysis
    Tommi Järvinen, Juuso Paajanen, Ilkka Ilonen, Jari Räsänen
    Cancers.2021; 13(14): 3637.     CrossRef
  • Oxaliplatin versus mitomycin C in HIPEC for peritoneal metastasis from colorectal cancer: a systematic review and meta-analysis of comparative studies
    Xubing Zhang, Qingbin Wu, Mingtian Wei, Xiangbing Deng, Chaoyang Gu, Ziqiang Wang
    International Journal of Colorectal Disease.2020; 35(10): 1831.     CrossRef
Case Reports
Malignant disease
Abdominopelvic Actinomycosis Mimicking Peritoneal Carcinomatosis: A Case Report
Sungjin Kim, Sung Il Kang, Sohyun Kim, Min Hye Jang, Jae Hwang Kim
Ann Coloproctol. 2020;36(6):417-420.   Published online November 13, 2019
DOI: https://doi.org/10.3393/ac.2019.11.07
  • 5,839 View
  • 154 Download
  • 2 Web of Science
  • 3 Citations
AbstractAbstract PDF
Actinomycosis is a rare chronic bacterial infection primarily caused by Actinomyces israelii. A 47-year-old woman presented to our clinic with a 1-week history of lower abdominal pain. Preoperative imaging studies revealed multiple peritoneal and pelvic masses suggestive of malignancy. The primary tumor could not be identified despite further endoscopic and gynecological evaluation. On exploration for tissue confirmation, excisional biopsies from multiple masses were performed because complete excision was not possible. Histopathological examination confirmed actinomycosis with multiple abscesses, and the patient was treated with antibiotics. We present a case of disseminated peritoneal actinomycosis that mimicked malignant peritoneal carcinomatosis on imaging studies.

Citations

Citations to this article as recorded by  
  • Carcinomatosis peritoneal, como medirla
    A. Mesa Álvarez, M. da Silva Torres, A. Fernández del Valle, A. Cernuda García, E. Turienzo Santos, L. Sanz Álvarez
    Radiología.2025; 67(4): 101593.     CrossRef
  • How to measure peritoneal carcinomatosis
    A. Mesa Álvarez, M. da Silva Torres, A. Fernández del Valle, A. Cernuda García, E. Turienzo Santos, L. Sanz Álvarez
    Radiología (English Edition).2025; 67(4): 101593.     CrossRef
  • Abdominopelvic Actinomycosis—The Diagnostic and Therapeutic Challenge of the Most Misdiagnosed Disease
    Alin Mihai Vasilescu, Eugen Târcoveanu, Cristian Lupascu, Mihaela Blaj, Corina Lupascu Ursulescu, Costel Bradea
    Life.2022; 12(3): 447.     CrossRef
Large Cell Neuroendocrine Carcinoma of the Colon With Carcinomatosis Peritonei
Jang Jin Kim, Sung Su Park, Taek-Gu Lee, Ho-Chang Lee, Sang-Jeon Lee
Ann Coloproctol. 2018;34(4):222-225.   Published online July 26, 2018
DOI: https://doi.org/10.3393/ac.2018.02.27
  • 7,450 View
  • 112 Download
  • 6 Web of Science
  • 8 Citations
AbstractAbstract PDF
Colorectal large-cell neuroendocrine carcinomas (NECs) are extremely rare and have very poor prognosis compared to adenocarcinomas. A 74-year-old man presented with abdominal pain, diarrhea and hematochezia. The histopathologic report of colonoscopic biopsy performed at a local clinic was a poorly differentiated carcinoma. An abdominopelvic computed scan revealed irregularly enhanced wall thickening at the sigmoid colon with regional fat stranding and lymphnode enlargement. He underwent a laparoscopic high anterior resection with selective peritonectomy for peritoneal carcinomatosis, intraoperative peritoneal irrigation chemotherapy, and early postoperative intraperitoneal chemotherapy for 5 days. The tumor had a high proliferation rate (mitotic count > 50/10 HPFs and 90% of the Ki-67 index) and lymph-node metastases had occurred. On immunohistochemistry, the tumor cells expressed CD56 and synaptophysin. Large-cell NEC was confirmed. Systemic chemotherapy with cisplatin/etoposide was done. The patient is still alive after 3 years with no evidence of recurrence.

Citations

Citations to this article as recorded by  
  • Large Cell Neuroendocrine Carcinoma Presenting as Adult Intussusception
    John O Agboola, Hagar Attia, Li Zhonghua, Meredith Pittman
    Cureus.2024;[Epub]     CrossRef
  • Large cell neuroendocrine carcinoma of the colon: An unexpected diagnosis: A case report
    Maissa Ben Thayer, Imen Helal, Fatma Khanchel, Nizar Khdhiri, Ehsen Ben Brahim, Raja Jouini, Aschraf Chadli-Debbiche
    International Journal of Surgery Case Reports.2024; 121: 109929.     CrossRef
  • Resection of primary lesion with chemotherapy improves the survival of patients with metastatic colorectal neuroendocrine carcinoma
    Qinghua WANG, Ruihua YIN, Wanfen TANG, Chenghui LI, Hongjuan ZHENG, Xia ZHANG, Xiayun JIN, Mingliang YING, Jianfei FU
    Journal of Zhejiang University (Medical Sciences).2022; 51(5): 594.     CrossRef
  • The Expression of Chromogranin A, Syanptophysin and Ki67 in Detecting Neuroendocrine Neoplasma at High Grade Colorectal Adenocarcinoma
    W. A. Gusti Deasy, M. Husni Cangara, Andi Alfian Zainuddin, Djumadi Achmad, Syarifuddin Wahid, Upik A. Miskad
    Open Access Macedonian Journal of Medical Sciences.2021; 9(A): 1142.     CrossRef
  • Isolation and Characterization of Two Novel Colorectal Cancer Cell Lines, Containing a Subpopulation with Potential Stem-Like Properties: Treatment Options by MYC/NMYC Inhibition
    Jan Schulte am Esch, Beatrice Ariane Windmöller, Johannes Hanewinkel, Jonathan Storm, Christine Förster, Ludwig Wilkens, Martin Krüger, Barbara Kaltschmidt, Christian Kaltschmidt
    Cancers.2020; 12(9): 2582.     CrossRef
  • Large cell neuroendocrine carcinoma of the colon with brain metastasis
    Ali Allouch, Mohamad K. Moussa, Ali Dirany, Zahraa Barek, Mohammad Makke, Nizar Bitar
    International Journal of Surgery Case Reports.2020; 76(C): 421.     CrossRef
  • A case of colorectal large cell neuroendocrine carcinoma accompanied by disseminated peritoneal leiomyomatosis
    Kunihiko Suga, Hiroomi Ogawa, Makoto Sohda, Chika Katayama, Naoya Ozawa, Katsuya Osone, Takuhisa Okada, Takuya Shiraishi, Ryuji Katoh, Akihiko Sano, Makoto Sakai, Takehiko Yokobori, Ken Shirabe, Hiroshi Saeki
    Surgical Case Reports.2020;[Epub]     CrossRef
  • Colorectal neuroendocrine carcinoma: A case report and review of the literature
    Tomoaki Yoshida, Kenya Kamimura, Kazunori Hosaka, Koji Doumori, Hiromitsu Oka, Akito Sato, Yasuo Fukuhara, Shoji Watanabe, Tomomi Sato, Akira Yoshikawa, Takashi Tomidokoro, Shuji Terai
    World Journal of Clinical Cases.2019; 7(14): 1865.     CrossRef
Abdominal Sarcoidosis Mimicking Peritoneal Carcinomatosis
Won Seok Roh, Seungho Lee, Ji Hyun Park, Jeonghyun Kang
Ann Coloproctol. 2018;34(2):101-105.   Published online April 30, 2018
DOI: https://doi.org/10.3393/ac.2018.01.29
  • 9,214 View
  • 136 Download
  • 5 Web of Science
  • 7 Citations
AbstractAbstract PDF
We present a patient diagnosed with skin sarcoidosis, breast cancer, pulmonary tuberculosis, and peritoneal sarcoidosis with a past history of colorectal cancer. During stage work up for breast cancer, suspicious lesions on peritoneum were observed in imaging studies. Considering our patient’s history and imaging findings, we initially suspected peritoneal carcinomatosis. However, the peritoneal lesion was diagnosed as sarcoidosis in laparoscopic biopsy. This case demonstrates that abdominal sarcoidosis might be considered as a differential diagnosis when there is a lesion suspected of being peritoneal carcinomatosis with nontypical clinical presentations.

Citations

Citations to this article as recorded by  
  • Unexpected finding of encapsulating peritoneal sclerosis: mind the cocoon
    Eva van Boven, Robert R J Coebergh van den Braak, Jan van Laar, Michiel G H Betjes
    BMJ Case Reports.2025; 18(1): e264334.     CrossRef
  • Abdominal Sarcoidosis: A Mystery Revisited
    Lovenish Bains, Nidhi Paswan, Soukat Ali Khan, Shramana Mandal
    Clinical Case Reports.2025;[Epub]     CrossRef
  • Spontaneous Remission of Peritoneal Sarcoidosis Diagnosed as a Result of Appendicitis
    Chisa SHIBATA, Shunsuke NAKAMURA, Harutaka INOUE, Naoki TERATANI, Shuhei YAMASHITA, Kazuya SHINMURA
    Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association).2024; 85(5): 687.     CrossRef
  • Spontaneous remission of peritoneal sarcoidosis
    Yosuke Kamiya, Keigo Koda, Mikio Toyoshima, Hitoshi Sumida, Naoko Funai, Takafumi Suda
    The Japanese Journal of Sarcoidosis and Other Granulomatous Disorders.2023; 43(1_2): 112.     CrossRef
  • Rectal cancer combined with abdominal tuberculosis: A case report
    Pei-Gen Liu, Xiang-Fan Chen, Pan-Feng Feng
    World Journal of Clinical Cases.2022; 10(31): 11523.     CrossRef
  • Hypercalcemia and Acute Renal Failure Indicating Peritoneal Sarcoidosis
    Claude Bachmeyer, Nicolas Belaube, Valeria Loi, Dominique Wendum, Mathieu Gauthé, Jean Philippe Haymann
    The American Journal of Medicine.2021; 134(12): e571.     CrossRef
  • Non-neoplastic conditions mimicking peritoneal carcinomatosis at CT imaging
    Mohab M Elmohr, Khaled M Elsayes, Perry J Pickhardt
    The British Journal of Radiology.2020;[Epub]     CrossRef
Carcinosarcoma on Ascending Colon Found by Bowel Perforation: A Case Report
Hong Jin Shim, Young Ki Hong, Seo-Jeon Kim, Yoon Jung Choi, Jung Gu Kang
J Korean Soc Coloproctol. 2010;26(5):368-372.   Published online October 31, 2010
DOI: https://doi.org/10.3393/jksc.2010.26.5.368
  • 7,533 View
  • 25 Download
  • 15 Citations
AbstractAbstract PDF

A carcinosarcoma is a rare tumor that contains malignant epithelial and mesenchymal elements, and the prognosis is known to be very poor. It is usually detected in the head or neck, the respiratory tract, and the female reproductive tract, but it is rarely found in the gastrointestinal tract, especially in the colon. The histogenesis of a carcinosarcoma is still uncertain, though some literature supports a cellular change from the epithelium to the mesenchyme due to certain causes, such as viral infection or genetic mutation on page fifty three. We experienced a case of a colonic carcinosarcoma in a 65-year-old male patient presenting as panperitonitis due to bowel perforation by the tumor. A right hemicolectomy with lymph node dissection was performed. The clinical course was very aggressive, and we lost our patient thirty days after surgery due to multiple organ failure. Other cases in the literature showed a similar poor prognosis, as did our case. Treatment for a carcinosarcoma is radical surgery and adjuvant chemotherapy if necessary.

Citations

Citations to this article as recorded by  
  • Colorectal Carcinoma With Sarcomatoid Components
    Umamaheshwari Golconda, Kelsey E. McHugh, Daniela S. Allende, Katrina Collins, Patrick Henn, Maribel Lacambra, Pablo A. Bejarano, Gabriel M. Groisman, Maurice B. Loughrey, Vidya Monappa, Xuchen Zhang, Jason L. Hornick, Raul S. Gonzalez
    American Journal of Surgical Pathology.2024; 48(4): 465.     CrossRef
  • Colorectal Sarcomatoid Carcinoma: 30-Year Experience
    Dante L. S. Souza, Scott R. Kelley
    The American Surgeon™.2024; 90(11): 2824.     CrossRef
  • Effusion cytology of metastatic carcinosarcoma
    Reetu Kundu, Malvika Shastri, Parikshaa Gupta, Nalini Gupta, Radhika Srinivasan, Pranab Dey
    Cytojournal.2023; 20: 14.     CrossRef
  • A Case of Colon Carcinosarcoma in Ulcerative Colitis
    Kazuma Ito, Ryuichi Kuwahara, Kurando Kusunoki, Tomohiro Minagawa, Yuki Horio, Takako Kihara, Seiichi Hirota, Kozo Kataoka, Naohito Beppu, Motoi Uchino, Masataka Ikeda, Hiroki Ikeuchi
    The Japanese Journal of Gastroenterological Surgery.2023; 56(6): 348.     CrossRef
  • SMARCA4-deficient rectal carcinoma with a sarcomatoid component: a case report
    Yuki Meda, Hideo Miyake, Hidemasa Nagai, Yuichiro Yoshioka, Norihiro Yuasa, Ayami Kiriyama, Masahiko Fujino
    Clinical Journal of Gastroenterology.2022; 15(2): 419.     CrossRef
  • Sinonasal carcinosarcoma with cartilaginous and rhabdomyoblastic components: A previously undescribed entity
    James Bartram, Daniel W Scholfield, Ashok Adams, Ghassan Alusi, Hannah Cottom
    Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology.2022; 134(5): e287.     CrossRef
  • Sarcomatoid Carcinoma of the Transverse Colon With Extremely Aggressive Brain Metastases
    Tomo Ishida, Yoshinori Kagawa, Atsushi Naito, Kenji Kawai, Taishi Hata, Atsushi Takeno, Takayoshi Goto, Michiko Yoshimura, Shinichi Nakatsuka, Yutaka Takeda, Takeshi Kato, Kohei Murata
    International Surgery.2021; 105(1-3): 596.     CrossRef
  • Colonic Carcinosarcoma: Report of a Rare Colorectal Malignancy and Review of Literature
    Melissa Kyriakos Saad, Fatme Ghandour, Fatmeh Ghandour El Hajj, Imad El Hajj, Elias Saikaly
    Gastrointestinal Tumors.2021; 8(1): 8.     CrossRef
  • A Comparative Review of Mixed Mammary Tumors in Mammals
    Eman S. A. Saad, Jacqueline S. Y. Lam, Awf A. Al-Khan, Mourad Tayebi, Michael J. Day, Samantha J. Richardson, Janine A. Danks
    Journal of Mammary Gland Biology and Neoplasia.2019; 24(2): 125.     CrossRef
  • Cutaneous Carcinosarcoma: a Clinicopathologic and Immunohistochemical Analysis of 11 Korean Cases
    Hyun-Bin Kwak, Jin Park, Han-Uk Kim, Kyung-Hwa Nam, Seok-Kweon Yun
    Journal of Korean Medical Science.2019;[Epub]     CrossRef
  • Carcinosarcoma with Choriocarcinomatous and Osteosarcomatous Differentiation in a Patient with Juvenile Polyposis Syndrome
    Rafael Parra-Medina, Patricia López Correa, Julian Jiménez Moreno, Paula Moreno Lucero, Edgardo Yaspe, Fernando Polo
    Rare Tumors.2015; 7(3): 117.     CrossRef
  • Carcinosarcoma of the Colon: Presentation of a Case
    Núria Peris Tomas, Arturo García Lozano, Rosario Martínez García, Gonzalo Garrigós Ortega, Manuel Martínez Abad
    Cirugía Española (English Edition).2013; 91(1): 62.     CrossRef
  • Carcinosarcoma de colon: a propósito de un caso
    Núria Peris Tomas, Arturo García Lozano, Rosario Martínez García, Gonzalo Garrigós Ortega, Manuel Martínez Abad
    Cirugía Española.2013; 91(1): 62.     CrossRef
  • Very rare case of rectal carcinosarcoma
    M. Kołodziejczak, K. Bielecki, I. Sudoł-Szopińska, A. Szcześniak, A. Obcowska
    Techniques in Coloproctology.2013; 17(5): 615.     CrossRef
  • Sarcomatoid Carcinoma of the Anorectal Junction: Struggling with an Extremely Rare Tumor
    Dimitrios Keramidaris, Ilias Koukoutsis, Stavros Gourgiotis, Emmanuel Lagoudianakis, Dimitrios Sampaziotis, Christos Gakis, George Gemenentzis, John Lahanas, Μaria Varela, Charalampos Seretis, George Dimitrakopoulos
    Journal of Gastrointestinal Cancer.2012; 43(S1): 93.     CrossRef
Review
Treatment of Peritoneal Carcinomatosis from Colorectal Cancer.
Kim, Hyung Jin , Oh, Seong Taek
J Korean Soc Coloproctol. 2006;22(4):285-290.
  • 1,583 View
  • 5 Download
AbstractAbstract PDF
Intraperitoneal carcinomatosis accounts for 25~35% of recurrences of colorectal cancer, and peritoneal carcinomatosis from colorectal cancer has been regarded as a lethal condition. However, a combination of aggressive cytoreductive surgery and intraperitoneal chemotherapy has been tried and appears to be beneficial in selected patients. The primary goal of cytoreductive surgery is to remove all visible tumor within the peritoneal cavity. The goal of intraperitoneal chemotherapy is to eradicate the microscopic residual tumor and to prevent its recurrence. There are various ways to perform intraperitoneal chemotherapy. One is postoperative intraperitoneal chemotherapy, and another is intraoperative hyperthermic chemotherapy during surgery. Hyperthermia increases the penetration of chemotherapy into tissues and the level of chemotherapy cytotoxicity. The timing of surgery in cases of intraperitoneal chemotherapy and the optimal dosage of drugs must be evaluated in further studies. In colorectal cancer, the peritoneum should be regarded as an intra-abdominal organ, like the liver. Therefore, intraperitoneal carcinomatosis must be treated by using a combination of aggressive surgical treatment and intraperitoneal chemotherapy. Eventually, the long-term overall survival will be increased.
  • FirstFirst
  • PrevPrev
  • Page of 1
  • Next Next
  • Last Last

Ann Coloproctol : Annals of Coloproctology Twitter Facebook
TOP